Figures computed from official regulatory filings — .
Analysttarget 12 USD (+193%) · consensus 3/5 · 0 buy · 1 hold · 0 sell
Ownershipinsiders 47.3% · institutions 0.1% · short 2.6% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Zivo Bioscience, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
252 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| STROME MARK Etrack record | Buy | $200K | conv 45 |
| SEC |
| YALDOO LAITH Ltrack record | Buy | $15K | conv 40Cluster | SEC |
| STROME GROUP, INC.track record | Buy | $195.4K | conv 51ClusterFirst in 12mo | SEC |
| STROME GROUP, INC.track record | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | ClusterFirst in 12mo | SEC |
| YALDOO LAITH Ltrack record | Buy | $25K | conv 40Cluster | SEC |
| PAYNE JOHN BERNARDtrack record | Buy | $100K | conv 90ClusterFirst in 12mo | SEC |
| Cornell Alison Atrack record | Buy | $100K | conv 62ClusterFirst in 12mo | SEC |
| YALDOO LAITH Ltrack record | Buy | $15K | conv 30 | SEC |
| Maggiore Christopher D.track record | Buy | $15K | conv 36 | SEC |
| YALDOO LAITH Ltrack record | Buy | $25K | conv 41Cluster | SEC |
| STROME INVESTMENT MANAGEMENT LP | Buy | $250K | conv 61ClusterFirst in 12mo | SEC |
| STROME INVESTMENT MANAGEMENT LP | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | ClusterFirst in 12mo | SEC |
| YALDOO LAITH Ltrack record | Buy | $20K | conv 27 | SEC |
| Maggiore Christopher D.track record | Buy | $284.4K | conv 63Unusual sizeFirst in 12mo | SEC |
| Cornell Alison Atrack record | AwardD (derivative) | $12.5K | SEC |
| Maggiore Christopher D.track record | AwardD (derivative) | $11K | SEC |
| YALDOO LAITH Ltrack record | AwardD (derivative) | $9.4K | SEC |
| YALDOO LAITH Ltrack record | Buy | $245K | conv 45Unusual size | SEC |
| YALDOO LAITH Ltrack record | BuyD (derivative) | $5K | SEC |
| YALDOO LAITH Ltrack record | Buy | $50K | conv 30 | SEC |
| Maggiore Christopher D.track record | Sell | $325 | SEC |
| YALDOO LAITH Ltrack record | Buy | $50.5K | conv 30 | SEC |
| YALDOO LAITH Ltrack record | Buy | $126.2K | conv 30 | SEC |
| STROME MARK Etrack record | Buy | $253.2K | conv 39ClusterFirst in 12mo | SEC |
| STROME MARK Etrack record | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | ClusterFirst in 12mo | SEC |